ENDRA Life Sciences (NDRA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.74, -7.06% vs the prior close of $5.10.
- Volume 14.19K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NDRA slides 7.1% to $4.74, a 1-month low. Closed at $4.74, -7.06% vs the prior close of $5.10. Day range $4.74–$5.00, opened at $4.81.
NDRA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NDRA slides 7.1% to $4.74, a 1-month low
- Closed at $4.74, -7.06% vs the prior close of $5.10. Day range $4.74–$5.00, opened at $4.81.
- Volume was 14.19K shares, 0.4x its 50-day average of 36.04K — lighter than usual.
- Price is -11.9% vs its 50-day average ($5.38) and -1.1% vs its 200-day average ($4.79).
- 52-week range $2.96–$7.55; today's close sits at 39% of that range, 37.2% below the 52-week high.
Oct 15, 2026 — NDRA jumps 6.8% to $5.10
- Closed at $5.10, +6.81% vs the prior close of $4.78. Day range $4.90–$5.14, opened at $4.95.
- Volume was 11.00K shares, 0.3x its 50-day average of 36.23K — lighter than usual.
- Price is -5.2% vs its 50-day average ($5.38) and +6.4% vs its 200-day average ($4.79).
- 52-week range $2.96–$8.00; today's close sits at 42% of that range, 36.3% below the 52-week high.
Oct 14, 2026 — NDRA slides 5.3% to $4.78, a 1-month low, 5 down days in a row
- Closed at $4.78, -5.26% vs the prior close of $5.04. Day range $4.73–$5.10, opened at $5.00.
- Volume was 15.00K shares, 0.4x its 50-day average of 36.18K — lighter than usual.
- Price is -11.0% vs its 50-day average ($5.37) and -0.4% vs its 200-day average ($4.79).
- 52-week range $2.96–$8.00; today's close sits at 36% of that range, 40.3% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — NDRA dips 1.9% to $5.04, a 1-month low, 4 down days in a row
- Closed at $5.04, -1.85% vs the prior close of $5.14. Day range $5.03–$5.10, opened at $5.07.
- Volume was 2.90K shares, 0.1x its 50-day average of 36.69K — lighter than usual.
- Price is -5.9% vs its 50-day average ($5.36) and +5.1% vs its 200-day average ($4.79).
- 52-week range $2.96–$9.85; today's close sits at 30% of that range, 48.8% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — NDRA slides 6.0% to $5.14, a 1-month low, 3 down days in a row
- Closed at $5.14, -5.95% vs the prior close of $5.46. Day range $5.05–$5.65, opened at $5.65.
- Volume was 15.80K shares, 0.4x its 50-day average of 36.75K — lighter than usual.
- Price is -3.8% vs its 50-day average ($5.34) and +7.1% vs its 200-day average ($4.80).
- 52-week range $2.96–$9.85; today's close sits at 32% of that range, 47.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — NDRA slides 7.9% to $5.46
- Closed at $5.46, -7.93% vs the prior close of $5.93. Day range $5.32–$6.01, opened at $5.81.
- Volume was 23.10K shares, 0.6x its 50-day average of 36.77K.
- Price is +2.4% vs its 50-day average ($5.33) and +13.9% vs its 200-day average ($4.79).
- 52-week range $2.96–$9.85; today's close sits at 36% of that range, 44.6% below the 52-week high.
Oct 8, 2026 — NDRA dips 2.1% to $5.93
- Closed at $5.93, -2.15% vs the prior close of $6.06. Day range $5.81–$6.48, opened at $6.00.
- Volume was 12.90K shares, 0.4x its 50-day average of 36.83K — lighter than usual.
- Price is +11.7% vs its 50-day average ($5.31) and +23.7% vs its 200-day average ($4.79).
- 52-week range $2.96–$9.85; today's close sits at 43% of that range, 39.8% below the 52-week high.
Oct 7, 2026 — NDRA rises 0.3% to $6.06
- Closed at $6.06, +0.33% vs the prior close of $6.04. Day range $5.91–$6.17, opened at $5.99.
- Volume was 7.50K shares, 0.2x its 50-day average of 36.85K — lighter than usual.
- Price is +14.8% vs its 50-day average ($5.28) and +26.5% vs its 200-day average ($4.79).
- 52-week range $2.96–$9.85; today's close sits at 45% of that range, 38.5% below the 52-week high.
Oct 6, 2026 — NDRA slides 4.3% to $6.04
- Closed at $6.04, -4.28% vs the prior close of $6.31. Day range $6.02–$6.40, opened at $6.40.
- Volume was 14.80K shares, 0.4x its 50-day average of 36.67K — lighter than usual.
- Price is +15.1% vs its 50-day average ($5.25) and +26.2% vs its 200-day average ($4.78).
- 52-week range $2.96–$9.85; today's close sits at 45% of that range, 38.7% below the 52-week high.
Oct 5, 2026 — NDRA jumps 4.1% to $6.31
- Closed at $6.31, +4.13% vs the prior close of $6.06. Day range $6.01–$6.31, opened at $6.09.
- Volume was 29.50K shares, 0.8x its 50-day average of 36.24K.
- Price is +20.9% vs its 50-day average ($5.22) and +32.0% vs its 200-day average ($4.78).
- 52-week range $2.96–$9.85; today's close sits at 49% of that range, 35.9% below the 52-week high.
Oct 2, 2026 — NDRA jumps 3.1% to $6.06
- Closed at $6.06, +3.06% vs the prior close of $5.88. Day range $5.91–$6.11, opened at $5.96.
- Volume was 39.70K shares, 1.1x its 50-day average of 35.73K.
- Price is +16.7% vs its 50-day average ($5.19) and +27.0% vs its 200-day average ($4.77).
- 52-week range $2.96–$9.85; today's close sits at 45% of that range, 38.5% below the 52-week high.
NDRA latest news & SEC filings
Every SEC filing by or about NDRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 8, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $159.94K (prior year -$1.23M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.06 (prior year -$1.71) (swung to profit vs Jun 30, 2025)
Things to know before you trade NDRA
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: Mar 31, 2026, Jul 9, 2025, May 15, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.39% (largest 14.7%). That is a volatile stock.
- Liquidity: about 24.46K shares (≈$115.94K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.74 vs a range of $2.96–$7.55 (39% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:35 on Nov 7, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 1, 2026; 8-K Aug 17, 2026; 10-Q Aug 14, 2026.
- Share count: 1.50M shares outstanding (Aug 14, 2026), +99.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
NDRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.81 | 5.00 | 4.74 | 4.74 | 14.19K |
| Oct 15, 2026 | 4.95 | 5.14 | 4.90 | 5.10 | 11.00K |
| Oct 14, 2026 | 5.00 | 5.10 | 4.73 | 4.78 | 15.00K |
| Oct 13, 2026 | 5.07 | 5.10 | 5.03 | 5.04 | 2.90K |
| Oct 12, 2026 | 5.65 | 5.65 | 5.05 | 5.14 | 15.80K |
| Oct 9, 2026 | 5.81 | 6.01 | 5.32 | 5.46 | 23.10K |
| Oct 8, 2026 | 6.00 | 6.48 | 5.81 | 5.93 | 12.90K |
| Oct 7, 2026 | 5.99 | 6.17 | 5.91 | 6.06 | 7.50K |
| Oct 6, 2026 | 6.40 | 6.40 | 6.02 | 6.04 | 14.80K |
| Oct 5, 2026 | 6.09 | 6.31 | 6.01 | 6.31 | 29.50K |
| Oct 2, 2026 | 5.96 | 6.11 | 5.91 | 6.06 | 39.70K |
| Oct 1, 2026 | 6.11 | 6.11 | 5.77 | 5.88 | 23.40K |
| Sep 30, 2026 | 6.05 | 6.06 | 5.79 | 5.96 | 27.70K |
| Sep 29, 2026 | 5.76 | 6.17 | 5.68 | 5.88 | 22.10K |
| Sep 28, 2026 | 5.94 | 6.39 | 5.70 | 5.80 | 25.80K |
| Sep 25, 2026 | 5.97 | 6.32 | 5.84 | 6.04 | 37.40K |
| Sep 24, 2026 | 6.63 | 6.63 | 5.90 | 5.93 | 32.40K |
| Sep 23, 2026 | 6.29 | 6.67 | 6.17 | 6.50 | 56.80K |
| Sep 22, 2026 | 6.37 | 6.37 | 5.91 | 6.23 | 40.70K |
| Sep 21, 2026 | 5.60 | 6.44 | 5.41 | 6.31 | 36.50K |
About ENDRA Life Sciences
ENDRA Life Sciences (NDRA) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in ANN ARBOR, MI. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1681682.
NDRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Lou Basenese | Director | Jan 23, 2026 |
| Anthony Digiandomenico | Director | Jan 23, 2026 |
| Michael Harsh | Director | Jan 23, 2026 |
| Alexander Y Tokman | Chief Executive Officer | Mar 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Richard Jacroux | Chief Financial Officer | Mar 4, 2026 |
| Alexander Y Tokman | Chief Executive Officer | Mar 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NDRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-7.03M | -8.93 | $-5.18M |
| Dec 31, 2024 | — | $-11.51M | -56.94 | $-7.40M |
| Dec 31, 2023 | — | $-10.06M | -2,766.85 | $-9.55M |
| Dec 31, 2022 | — | $-13.18M | — | $-12.77M |
| Dec 31, 2021 | — | $-11.23M | — | $-11.12M |
Latest balance sheet: total assets $7.94M, total liabilities $1.63M, cash $1.74M (as of Jun 30, 2026).
NDRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $4.49 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $4.65 |
| Jul 9, 2025 | 8-K Item 2.02 (results) | $8.84 |
| May 15, 2025 | 8-K Item 2.02 (results) | $3.21 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $4.10 |
| Nov 15, 2024 | 8-K Item 2.02 (results) | $4.54 |
| Aug 23, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Mar 28, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NDRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.